+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Plasma Derivatives Market - Global Forecast 2026-2032- Product Image
Blood Plasma Derivatives Market - Global Forecast 2026-2032- Product Image
New

Blood Plasma Derivatives Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010980
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Blood plasma derivatives form a cornerstone of modern medical therapies, supporting a broad range of treatments in hematology, immunology, and critical care. As the market navigates heightened regulatory expectations and advances in recombinant technology, stakeholders face an evolving landscape where operational excellence and innovation drive long-term viability.

Market Snapshot: Blood Plasma Derivatives Market Size and Growth

The Blood Plasma Derivatives Market grew from USD 30.24 billion in 2025 to USD 32.15 billion in 2026. It is expected to continue growing at a CAGR of 6.77%, reaching USD 47.85 billion by 2032.

Scope & Segmentation

  • Source: Includes plasma-derived and recombinant products, with recombinant further segmented into Factor IX and Factor VIII.
  • End User: Focus areas are Hemophilia Treatment Centers, Home Care settings, and Hospitals, each shaping care models and supply logistics.
  • Distribution Channel: Comprises Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Specialist Clinics, offering varied access points and compliance structures.
  • Product Type: Covers Albumin, Coagulation Factor (Factor IX, Factor VIII, Fibrin Sealant), and Immunoglobulin (Hyperimmune, Intravenous, Subcutaneous).
  • Application: Spans Hemophilia Treatment, Neurological Disorders, and Primary Immunodeficiency, impacting clinical endpoints and industry priorities.
  • Regions: Analysis includes Americas, EMEA (Europe, Middle East & Africa), and Asia-Pacific, addressing unique regulatory, capacity, and access dynamics.
  • Technologies: Advanced fractionation, pathogen reduction, recombinant platforms, and digital traceability support safety, yield, and distribution efficiency.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Blood plasma derivatives underpin vital treatments and require robust supply continuity to safeguard patient outcomes.
  • Technological advances in manufacturing, automation, and data-driven quality systems are improving product safety and operational agility.
  • Heightened regulatory oversight on traceability and pharmacovigilance demands ongoing investments in compliance infrastructure.
  • Vertical integration and strategic partnerships enhance resilience, accelerate recombinant therapy pipelines, and allow companies to navigate market fluctuations effectively.
  • Regional strategies must balance mature donor networks and centralized procurement with emerging market growth and evolving reimbursement landscapes.
  • Emphasis on differentiated delivery formats and patient support structures is influencing how therapies reach a broader range of clinical settings.

Tariff Impact on Supply Chains and Access Pathways

Tariffs and trade restrictions reshape supply chains by increasing input costs and prompting sourcing diversification. Manufacturers adapt through localized inputs or long-term supply agreements to mitigate price volatility. Distribution flows and regional manufacturing investments adjust in response, sometimes creating variations in product availability. These shifts may alter formulary options and procurement cycles for payers and providers, influencing both commercial and clinical strategies at a market level. Trade measures also encourage new licensing models and joint ventures to sustain market reach while managing cost pressures.

Methodology & Data Sources

This analysis integrates structured expert interviews with clinicians, supply chain leaders, and regulatory specialists, alongside targeted secondary research from peer-reviewed literature, regulatory documents, and market disclosures. Triangulation and scenario analysis ensure a rigorous, evidence-based approach to trend identification and operational implications.

Why This Report Matters

  • Equips leadership teams with actionable intelligence to navigate clinical, operational, and policy complexities in a dynamic industry.
  • Highlights segment-specific and technology-driven opportunities for investment and partnership.
  • Supports strategic decision-making by revealing the implications of regulatory changes, supply chain modernization, and regional market drivers.

Conclusion

Operational resilience, innovation investment, and cross-stakeholder collaboration are vital for advancing blood plasma derivative therapies. Decision-makers can position their organizations for sustainable growth by aligning supply strategies, compliance, and patient access initiatives within this dynamic market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Blood Plasma Derivatives Market, by Product Type
8.1. Albumin
8.2. Coagulation Factor
8.2.1. Factor IX
8.2.2. Factor VIII
8.2.3. Fibrin Sealant
8.3. Immunoglobulin
8.3.1. Hyperimmune
8.3.2. Intravenous
8.3.3. Subcutaneous
9. Blood Plasma Derivatives Market, by Source
9.1. Plasma Derived
9.2. Recombinant
9.2.1. Factor IX
9.2.2. Factor VIII
10. Blood Plasma Derivatives Market, by Distribution Channel
10.1. Online
10.2. Offline
11. Blood Plasma Derivatives Market, by Application
11.1. Hemophilia Treatment
11.2. Neurological Disorders
11.3. Primary Immunodeficiency
12. Blood Plasma Derivatives Market, by End User
12.1. Hemophilia Treatment Centers
12.2. Home Care
12.3. Hospitals
13. Blood Plasma Derivatives Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Blood Plasma Derivatives Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Blood Plasma Derivatives Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Blood Plasma Derivatives Market
17. China Blood Plasma Derivatives Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Bharat Serums and Vaccines Limited
18.6. Bio Products Laboratory Limited (BPL)
18.7. Biotest AG
18.8. China Biologic Products Holdings, Inc.
18.9. CSL Behring GmbH
18.10. Emergent BioSolutions Inc.
18.11. Grifols, S.A.
18.12. Hualan Biological Engineering Inc.
18.13. Intas Pharmaceuticals Ltd.
18.14. Kamada Ltd.
18.15. Kedrion S.p.A.
18.16. LFB S.A.
18.17. Octapharma AG
18.18. Reliance Life Sciences Pvt. Ltd.
18.19. Sanquin Plasma Products B.V.
18.20. Shanghai RAAS Blood Products Co., Ltd.
18.21. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
18.22. SK Plasma Co., Ltd.
18.23. Takeda Pharmaceutical Company Limited
List of Figures
FIGURE 1. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLOOD PLASMA DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FIBRIN SEALANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FIBRIN SEALANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HYPERIMMUNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HYPERIMMUNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HYPERIMMUNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PLASMA DERIVED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PLASMA DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 113. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 114. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 116. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 131. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 132. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 133. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 134. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 150. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 151. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 152. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 153. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. ASEAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 159. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 160. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 161. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 162. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. GCC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 177. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 178. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 179. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 180. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. BRICS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 185. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 186. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 187. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 188. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 189. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. G7 BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 195. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 196. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 197. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 198. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. NATO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2032 (USD MILLION)
TABLE 214. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2032 (USD MILLION)
TABLE 215. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 216. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 217. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Blood Plasma Derivatives market report include:
  • Bharat Serums and Vaccines Limited
  • Bio Products Laboratory Limited (BPL)
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • CSL Behring GmbH
  • Emergent BioSolutions Inc.
  • Grifols, S.A.
  • Hualan Biological Engineering Inc.
  • Intas Pharmaceuticals Ltd.
  • Kamada Ltd.
  • Kedrion S.p.A.
  • LFB S.A.
  • Octapharma AG
  • Reliance Life Sciences Pvt. Ltd.
  • Sanquin Plasma Products B.V.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • SK Plasma Co., Ltd.
  • Takeda Pharmaceutical Company Limited

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 32.15 Billion
Forecasted Market Value ( USD ) by 2032 $ 47.85 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Blood Plasma Derivatives Market Report 2025 - Product Image

Blood Plasma Derivatives Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033 - Product Image

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033

  • Report
  • 149 Pages
  • Global
From
Blood Plasma Derivatives Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Blood Plasma Derivatives Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Bovine Blood Plasma Derivatives - Global Strategic Business Report - Product Image

Bovine Blood Plasma Derivatives - Global Strategic Business Report

  • Report
  • 289 Pages
  • Global
From
Blood Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From

About the Plasma Derivative Market

The Plasma Derivative market is a subset of the Blood Banking industry, which involves the collection, processing, and distribution of human blood and its components. Plasma derivatives are products derived from human plasma, such as albumin, immunoglobulins, and clotting factors. These products are used to treat a variety of medical conditions, including hemophilia, immune deficiencies, and shock. Plasma derivatives are typically collected from healthy donors and processed in a laboratory setting. The process involves separating the plasma from the other components of the blood, such as red and white blood cells. The plasma is then further processed to create the desired product. The Plasma Derivative market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products. Companies in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.